𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bortezomib as a Treatment Option in Patients With Waldenström Macroglobulinemia

✍ Scribed by Meletios A. Dimopoulos; Christine Chen; Efstathios Kastritis; Maria Gavriatopoulou; Steven P. Treon

Book ID
119936222
Publisher
Elsevier
Year
2010
Tongue
English
Weight
306 KB
Volume
10
Category
Article
ISSN
2152-2650

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly bortezomib in c
Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia
✍ Irene M. Ghobrial; Wanling Xie; Swaminathan Padmanabhan; Ashraf Badros; Meghan R 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB 👁 1 views

## Abstract This study aimed to determine the activity and safety of weekly bortezomib and rituximab in patients with untreated Waldenström Macroglobulinemia (WM). Patients with no prior therapy and symptomatic disease were eligible. Patients received bortezomib IV weekly at 1.6 mg/m^2^ on days 1,